$5.01 +0.01 (0.20%) Titan Pharmaceuticals Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 5.01
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: +0.01 (0.20%)
Prev Close: 5.00
Open: 4.99
Bid: 4.99
Ask: 5.01
  1. No results found.
  1. Trading of Titan Pharmaceuticals Stock Halted Today

    GuruFocus | Jan. 12, 2016 | 23:03PM EST
  2. Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee ...

    GuruFocus | Dec. 9, 2015 | 23:06PM EST
  3. Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction

    Benzinga | Dec. 9, 2015 | 07:00AM EST
  4. Titan Pharmaceuticals Announces FDA's Acceptance of Resubmission of New Drug Application for ...

    GuruFocus | Sep. 29, 2015 | 00:03AM EST
  5. Titan Pharmaceuticals Announces Reverse Stock Split

    GuruFocus | Sep. 29, 2015 | 00:02AM EST
  6. Titan Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference

    GuruFocus | Sep. 4, 2015 | 00:02AM EST
  7. Titan Pharmaceuticals Announces Resubmission of the New Drug Application for Probuphine for the ...

    GuruFocus | Sep. 1, 2015 | 00:03AM EST
  8. Titan Pharmaceuticals Reports Second Quarter 2015 Financial Results

    GuruFocus | Aug. 14, 2015 | 00:04AM EST
  9. Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2015 Financial Results

    GuruFocus | Aug. 12, 2015 | 00:02AM EST
  10. Titan Pharmaceuticals Presents Nonclinical Data Supporting Use of ProNeura Drug Delivery ...

    GuruFocus | Jun. 18, 2015 | 01:07AM EST
  11. Roth Capital's 4 Reasons to be Bullish on Titan Pharmaceuticals

    GuruFocus | Jan. 26, 2015 | 12:07PM EST
  12. Titan Pharmaceuticals to Present at 8th Annual OneMedForum

    GuruFocus | Jan. 6, 2015 | 11:01AM EST
  13. Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for ...

    GuruFocus | Nov. 20, 2014 | 11:05AM EST
  14. Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2014 Financial Results

    GuruFocus | Nov. 7, 2014 | 11:04AM EST
Trading Center